Company Overview
Snapshot
Founded in January 1992 by Aaron Esteron, Estar Medical operates with 11–50 employees. The company specializes in medical devices for biologics, cell therapy, and platelet-rich plasma fields, and in August 2019, it successfully won a significant legal dispute against Regenlab regarding a PRP patent in the UK High Court.
Business overview
Estar Medical develops patented platform technology for producing autologous platelet-rich plasma and other cell therapy solutions for human use. Its products, distributed under the Tropocells and Cellenis trademarks, process patient blood to utilize platelets, cells, and essential proteins across various medical disciplines. The company serves markets including dermatology, aesthetics, orthopedics, sports medicine, wound care, pain management, dental, ophthalmology, and veterinary, operating within the Health Tech & Life Sciences sector.
Strategic signal
In August 2019, Estar Medical secured a significant legal victory against Regenlab in the UK High Court, which revoked Regenlab's PRP patent and awarded Estar Medical extensive legal costs. This outcome, consistent with previous decisions by the European Patent Office and the Federal Court in New York, reinforces Estar Medical's intellectual property position and validates its leadership in the biologics, cell therapy, and platelet-rich plasma medical device fields, signaling strong market protection and competitive advantage.
Log in to access full profile ›Company Intelligence Q&A
- What is Estar Medical's core product offering?
- Estar Medical offers a patented platform method for producing autologous platelet-rich plasma and related cell therapy technologies. These products, marketed under the Tropocells and Cellenis trademarks, process a patient's own blood for therapeutic applications.
- Which medical disciplines does Estar Medical's technology serve?
- Estar Medical's products are applied across various medical disciplines including dermatology, aesthetics, orthopedics, sports medicine, wound care, pain management, dental, ophthalmology, and veterinary medicine.
- What was the outcome of the legal dispute between Estar Medical and Regenlab?
- In August 2019, Estar Medical won a legal dispute against Regenlab in the UK High Court, which resulted in the revocation of Regenlab's PRP patent and awarded Estar Medical extensive legal costs. This decision aligned with previous rulings from the European Patent Office and the Federal Court in New York.
- What certifications and approvals does Estar Medical hold for its products?
- Estar Medical's Tropocells and Cellenis product portfolio is based on a proprietary patented technology that is US FDA cleared for orthopedic applications, CE certified (Class IIb), and ISO 13485 approved, operating under strict GMP standards.
- Who is the founder of Estar Medical?
- Estar Medical was founded by Aaron Esteron in January 1992.